cilostamide and isoproterenol

cilostamide has been researched along with isoproterenol in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19903 (17.65)18.7374
1990's4 (23.53)18.2507
2000's5 (29.41)29.6817
2010's5 (29.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, NS; Kim, KY; Kim, SH; Lee, H; Yoo, SE1
Belfrage, P; Calvo, J; Manganiello, VC; Smith, CJ; Vasta, V1
Crankshaw, D; Haslam, RJ; Maurice, DH1
Malik, KU; Williams, JL1
Elks, ML; Manganiello, VC1
Endoh, M; Satoh, K; Yamashita, S1
Malik, KU; Schwartz, DD; Williams, JL1
Carey, GB; Finnegan, RB1
Greenberg, AG; Kraemer, FB; Xue, B; Zemel, MB1
Kaumann, A; Molenaar, P; Semmler, AB1
Galindo-Tovar, A; Kaumann, AJ1
Abi-Gerges, A; Conti, M; Fischmeister, R; Lechêne, P; Leroy, J; Mazet, JL; Nikolaev, VO; Richter, W; Vandecasteele, G1
Galindo-Tovar, A; Kaumann, AJ; Vargas, ML1
Arnoletti, E; Baragli, A; Ghè, C; Ghigo, E; Granata, R; Muccioli, G1
Afzal, F; Aronsen, JM; Hussain, RI; Krobert, KA; Levy, FO; Osnes, JB; Sjaastad, I; Skomedal, T1
Andersen, GØ; Ata, SH; Dahl, CP; Levy, FO; Orstavik, O; Osnes, JB; Qvigstad, E; Riise, J; Skomedal, T1
Belacel-Ouari, M; Domergue-Dupont, V; Fischmeister, R; Hubert, F; Joubert, F; Leblais, V; Manoury, B; Mateo, P; Zhai, K1

Other Studies

17 other study(ies) available for cilostamide and isoproterenol

ArticleYear
Discovery of new inhibitor for PDE3 by virtual screening.
    Bioorganic & medicinal chemistry letters, 2011, Mar-15, Volume: 21, Issue:6

    Topics: Adipocytes; Animals; Drug Discovery; Humans; Mice; Models, Molecular; Molecular Structure; Phosphodiesterase 3 Inhibitors

2011
Insulin and isoproterenol induce phosphorylation of the particulate cyclic GMP-inhibited, low Km cyclic AMP phosphodiesterase (cGI PDE) in 3T3-L1 adipocytes.
    Biochemical and biophysical research communications, 1992, Mar-31, Volume: 183, Issue:3

    Topics: 3T3 Cells; Adipose Tissue; Animals; Blotting, Western; Cell Differentiation; Cross Reactions; Insulin; Isoproterenol; Mice; Phosphorylation; Protein Kinases; Quinolones

1992
Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle.
    European journal of pharmacology, 1991, Jan-10, Volume: 192, Issue:2

    Topics: Adenylyl Cyclases; Animals; Aorta; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Isoproterenol; Male; Molsidomine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Quinolones; Rats; Rats, Inbred Strains; Vasodilator Agents

1991
Inhibitory modulation by cAMP of isoproterenol-induced prostacyclin synthesis in rabbit heart.
    The American journal of physiology, 1989, Volume: 257, Issue:4 Pt 2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 6-Ketoprostaglandin F1 alpha; Adenylyl Cyclase Inhibitors; Animals; Blood Pressure; Colforsin; Cyclic AMP; Epoprostenol; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardium; Phenylisopropyladenosine; Platelet Aggregation Inhibitors; Quinolones; Rabbits; Thionucleotides

1989
Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Endocrinology, 1985, Volume: 116, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue; Animals; Enzyme Activation; Insulin; Isoproterenol; Lipolysis; Quinolines; Quinolones; Rats

1985
Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
    European journal of pharmacology, 1980, Aug-22, Volume: 66, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Dogs; Female; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Quinolines; Quinolones; Rabbits; Theophylline

1980
Contribution of calcium to isoproterenol-stimulated lipolysis in the isolated perfused rabbit heart.
    The American journal of physiology, 1993, Volume: 265, Issue:3 Pt 1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Calcium Channel Blockers; Cyclic AMP; Diltiazem; Gallic Acid; Glycerol; Heart; In Vitro Techniques; Isoproterenol; Lipolysis; Male; Myocardium; Quinolones; Rabbits

1993
Characterization of cyclic AMP efflux from swine adipocytes in vitro.
    Obesity research, 1998, Volume: 6, Issue:4

    Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Antimycin A; Cells, Cultured; Colforsin; Cyclic AMP; Isoproterenol; Probenecid; Quinolones; Swine; Swine, Miniature; Xanthines

1998
Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:13

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Androstadienes; Bucladesine; Calcium; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Insulin; Isoproterenol; Lipolysis; Phosphodiesterase Inhibitors; Phosphorylation; Potassium Chloride; Quinolones; Sterol Esterase; Wortmannin; Xanthines

2001
The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Aged; Animals; Atrial Appendage; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Synergism; Female; Humans; Isometric Contraction; Isoproterenol; Male; Middle Aged; Norepinephrine; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Receptors, Adrenergic, beta-1; Rolipram; Signal Transduction

2007
Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Female; Heart Atria; Heart Rate; Heart Ventricles; Imidazoles; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Rolipram; Sinoatrial Node; Tachycardia, Sinus; Tachycardia, Ventricular

2008
Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.
    Circulation research, 2008, May-09, Volume: 102, Issue:9

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adrenergic beta-Agonists; Animals; Biosensing Techniques; Calcium Channels, L-Type; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide-Gated Cation Channels; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Fluorescence Resonance Energy Transfer; Guanine Nucleotide Exchange Factors; Heart Ventricles; Isoproterenol; Kinetics; Male; Membrane Potentials; Microscopy, Fluorescence; Myocardial Contraction; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Quinolones; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Sarcolemma; Signal Transduction; Transfection

2008
Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Naunyn-Schmiedeberg's archives of pharmacology, 2009, Volume: 379, Issue:4

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Arrhythmia, Sinus; Atrial Function, Left; Atrial Function, Right; Bradycardia; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Partial Agonism; Female; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Stimulation, Chemical; Tachycardia

2009
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B.
    Biochimica et biophysica acta, 2011, Volume: 1811, Issue:6

    Topics: Acylation; Adipocytes; Adrenergic beta-Agonists; Animals; Benzimidazoles; Blotting, Western; Cells, Cultured; Class Ib Phosphatidylinositol 3-Kinase; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Drug Interactions; Ghrelin; Glycerol; Intra-Abdominal Fat; Isoproterenol; Lipolysis; Male; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; Quinoxalines; Rats; Rats, Wistar; Thiazolidinediones

2011
The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
    Journal of molecular and cellular cardiology, 2013, Volume: 56

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cardiotonic Agents; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Failure; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Muscarinic Agonists; Myocardial Contraction; Myocardial Infarction; Pertussis Toxin; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Quinolones; Rats; Rats, Wistar; Rolipram; Ventricular Pressure

2013
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
    British journal of pharmacology, 2014, Volume: 171, Issue:23

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiotonic Agents; Heart; Heart Failure; Humans; Hydrazones; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Pyridazines; Quinolines; Quinolones; Rats, Wistar; Rolipram; Simendan; Thiadiazines

2014
Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4.
    British journal of pharmacology, 2014, Volume: 171, Issue:23

    Topics: Adrenergic beta-Agonists; Animals; Aorta, Thoracic; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dinoprost; Endothelium, Vascular; Gene Expression; Heart Failure; In Vitro Techniques; Isoproterenol; Male; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Quinolones; Rats, Wistar; RNA, Messenger; Vasoconstriction

2014
chemdatabank.com